OVARIAN CANCER and US: study

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label study. Show all posts
Showing posts with label study. Show all posts

Tuesday, February 07, 2012

(repost) Genomethics - background and Questionnaire UK



Questionnaire


This ethics and genomics study is being conducted by two Ethics Researchers. The team consists of:
Dr Anna Middleton, Ethics Researcher and Registered Genetic Counsellor,
and
Prof Mike Parker, Professor of Bioethics and Director of the Ethox Centre, University of Oxford
The two Ethics Researchers are part of the Deciphering Developmental Disorders (DDD) Study based at the Wellcome Trust Sanger Institute, Cambridge, UK. More information about the DDD study can be found here: www.ddduk.org
The DDD study involves a large team of scientists and informaticians and the Principal Investigators are:
  • Dr Nigel Carter, molecular cytogeneticist, Wellcome Trust Sanger Institute, Cambridge, UK
  • Dr Helen Firth, consultant clinical geneticist, Addenbrooke's Hospital, Cambridge, UK
  • Dr Matt Hurles, molecular geneticist, Wellcome Trust Sanger Institute, Cambridge, UK
  • Dr Jeff Barrett, statistical geneticist, Wellcome Trust Sanger Institute, Cambridge, UK
  • Prof David Fitzpatrick, consultant clinical geneticist, Western General Hospital, Edinburgh, UK
  • Prof Mike Parker, professor of bioethics, Director of Ethox, University of Oxford, UK

Saturday, September 25, 2010

U.S. - Stanford study of program for cancer survivors needs participants



Now, researchers at the Stanford University School of Medicine are looking for participants for a study on the program, which was designed to help people get the most out of life while living with cancer. This study is specifically for patients who have had cancer more than once.
Participants are needed who have had at least two bouts of cancer and have completed major treatment in the past five years. Participants can live anywhere in the United States but need access to a computer with an Internet connection and an e-mail account.
Those who are interested in participating should visit http://cancersurvivors.stanford.edu or e-mail cancersurvivors@stanford.edu.
“Cancer: Thriving and Surviving” is a six-week, Internet-based workshop intended to help people living with cancer deal with their unique problems and concerns, which can include fear of reoccurrence, depression, fatigue and a sense of isolation. Each workshop brings together online about 25 people and is facilitated by two trained moderators — at least one of whom is a cancer survivor, like Gaynor Watson.

The study will assess the workshop’s effectiveness.

The workshop is an adaptation of a chronic-disease-management program developed by Kate Lorig, DrPH, professor emeritus of immunology and rheumatology, that has been shown to be effective at improving health and well-being for participants.

To evaluate this new program, Lorig and colleagues at the University of Hawaii previously enrolled 400 first-time cancer survivors in the cancer course; now the study has been expanded to include patients with a recurring or second cancer.
Gaynor Watson said past participants have benefited from the sense of camaraderie with their online peers and from the ability to communicate with others who relate to what they’re doing. Her hope, she said, is that they also walk away with “a sense of self-empowerment and the skills to live a quality life.”

During the study, survivors will be randomly assigned to participate in a workshop, or to wait six months to take the workshop. Those enrolled in the online program will have access to a Web-based learning center and online discussion boards to address such topics as healthy eating, physical activity, stress and fatigue management, communication and emotional strategies. They’ll be asked to log on two or three times for a total of about two hours each week over the six-week period; all participants will complete two online questionnaires about their health over a six-month period.

The study, which is being conducted in the Stanford Patient Education Research Center, is funded by the Stanford Cancer Center.